NEW YORK (GenomeWeb) – Three main mutational signatures most often mark esophageal squamous cell carcinomas from China, according to a study published online today in the American Journal of Human Genetics.

Chinese researchers did whole-exome sequencing on matched tumor-normal samples from 90 individuals with esophageal squamous cell carcinoma from China's Taihang Mountains and whole-genome sequencing on samples from another 14 individuals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Dec
05
Sponsored by
Agilent

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.